The Human Side of Forecasting – Avoiding pitfalls facing Business Review Committees

The role of the forecaster extends beyond the modelling and the numbers, and all too often you may find yourself presenting cross-departmentally to your organisational equivalent of a Business Review Committee, for example, or to another organisation. This may not be an ad-hoc event, but many months of bringing all the pieces together may lead up to this day, when your work is being scrutinized from many different perspectives.

In our November forum we will explore potential pitfalls, and how to increase the chances of success during those meetings. We are delighted to introduce Florent Edouard, now Global Head of Commercial Excellence at Grünenthal, who will introduce the topic and share some of his experiences from working in senior commercial roles at AstraZeneca and at Grünenthal with us.

‘The Human Side of Forecasting’ Avoiding pitfalls facing Business Review Committees – Presenting the Committee Perspective

  • Who typically are the Committee members?
  • What are Committee members looking for?
  • What is the context of the Forecast?
  • Why is it needed?
  • What resonates?
  • Factors behind unsuccessful reviews: Those under our control and those that are not.
  • Q&A / Discussion

If this is of interest please contact us so that we can provide connection details for you to join us on 13 November, 2020

Post CoVID-19: a new normal for carbon emissions in Pharma Market Research?

During the CoVID lockdown, have you thought to yourself: wow, our industry’s carbon emissions must have gone down dramatically? Would you be curious to find out by just how much? Erik Holzinger will be chairing a webinar by Bors Hulesch, of Brains & Cheek, looking at this very issue.

Tuesday 6th October – 15.00 – 15.40 UK time – Post CoVID-19: a new normal for carbon emissions in Pharma Market Research?

The sustainability team at Brains & Cheek, an EphMRA agency member, was conducting a carbon audit of the pharma market research industry, just before the lockdown kicked in. Now they are in the process of collecting the same data for the lockdown period, so that they can compare the two data sets. As part of this talk, you will also be treated to some modelling scenarios: what would it look like if we returned to business as usual, and what if there were a second wave of Coronavirus. At the end of the talk, you will be invited to share your views on how the pharma market research industry should move forward on carbon emissions, based on the data presented.

If you are involved in business sustainability or corporate social responsibility (or just concerned for the future of our planet!), this talk should be of interest, so please join us.

This webinar is free to attend, but only available to EphMRA members. Click here to register

Please register at least 30 minutes in advance in order to receive approval and join.